{"id":"W1987135361","doi":"10.1093/neuonc/noq016","title":"Temozolomide and MGMT forever?","year":2010,"lang":"en","type":"editorial","venue":"Neuro-Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Temozolomide; Medicine; Dacarbazine; Oncology; Internal medicine; Clinical trial; Glioma; Chemotherapy; Clinical endpoint; Progression-free survival; Cancer; Phases of clinical research; Cancer research","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0001829522,0.0003930179,0.001059806,0.0001939929,0.00008938637,0.00002497888,0.0001363283,0.002005363,0.0001518088],"category_scores_gemma":[0.001430311,0.0003155457,0.000170122,0.00009469347,0.0001890034,0.00003556764,0.0001579748,0.001658747,0.0001309267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002129872,"about_ca_system_score_gemma":0.0007201436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007091143,"about_ca_topic_score_gemma":0.0002616817,"domain_scores_codex":[0.9980382,0.00009613833,0.0003833575,0.0006841079,0.0003777993,0.0004203428],"domain_scores_gemma":[0.9965671,0.002187587,0.0002402908,0.0005119115,0.0001748925,0.0003181663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001887643,0.0003909958,0.0008911673,0.00008239904,0.0001191253,0.001753584,0.00004004062,5.878623e-8,0.01742808,0.00003598577,0.9563854,0.02268441],"study_design_scores_gemma":[0.004434188,0.002512032,0.0004013329,0.00004421815,0.0006359253,0.0002161855,0.00001051409,0.000004351145,0.002408303,0.0001053449,0.9890273,0.0002003268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.03290469,0.0008712963,0.000001294568,0.003932484,0.9533113,0.0008694488,0.0001292024,0.0001098335,0.007870412],"genre_scores_gemma":[0.00751552,0.001968942,0.0005323596,0.001431399,0.9873102,0.0003102936,0.0005080677,0.0001382643,0.0002849018],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.03399891,"threshold_uncertainty_score":0.9999297,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01264403009274546,"score_gpt":0.3051382854290138,"score_spread":0.2924942553362684,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}